Veradermics (MANE) Other Accumulated Expenses (2025 - 2026)

Veradermics (MANE) has 2 years of Other Accumulated Expenses data on file, last reported at $39000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $39000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39000.0 (changed N/A YoY) and the FY2025 annual result came in at $47000.0, changed N/A from the prior year.
• Other Accumulated Expenses retreated to $39000.0 in Q1 2026, from $47000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $47000.0 in Q4 2025 to a low of $39000.0 in Q1 2026.